Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Quick ratio | 8.3x | 10.4x | 2.8x | 6.1x | 4.3x | 5.4x | 1.6x | 8.4x | 6.3x | 3.0x | 3.3x | 2.7x | 3.5x | 3.7x | 3.0x | 2.7x | 3.4x | 3.4x | 4.8x | 3.9x |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Microsoft Corp's last 12-month Quick ratio is 29.7x, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual Quick ratio for Regeneron Pharmaceuticals, Inc. have been 5.7x over the past three years, and 5.1x over the past five years.
As of today, Regeneron Pharmaceuticals, Inc.'s Quick ratio is 29.7x, which is higher than industry median of 4.2x. It indicates that Regeneron Pharmaceuticals, Inc.'s Quick ratio is Good.